Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
05 Janeiro 2024 - 6:30PM
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a
leading global medical technology company, announced today
that Jan De Witte, president and chief executive officer will
present at the 42nd Annual J.P. Morgan
Healthcare conference on January 10, 2024 at 1:30pm ET.
A live webcast of the presentation will be
available on the Integra LifeSciences investor relations website at
http://investor.integralife.com/events-and-presentations.
About Integra LifeSciencesAt Integra
LifeSciences, we are driven by our purpose of restoring patients’
lives. We innovate treatment pathways to advance patient
outcomes and set new standards of surgical, neurologic, and
regenerative care. We offer a comprehensive portfolio of high
quality, leadership brands that include AmnioExcel®, Aurora®,
Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus,
Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®,
ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®,
MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®,
SurgiMend®, TCC-EZ® and VersaTru®. For the latest news
and information about Integra and its products, please
visit www.integralife.com.
Investor Relations:Chris
Ward(609) 772-7736chris.ward@integralife.com
Media Contact:Laurene
Isip(609) 208-8121laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
Integra LifeSciences (NASDAQ:IART)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Integra LifeSciences (NASDAQ:IART)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024